VEGFR-2-specific forms of VEGF-D and VEGF-C and uses thereof

Forskningsoutput: PatentVetenskaplig

Sammanfattning

Amino-terminal truncated forms of Vascular Endothelial Growth Factor-D (VEGF-D) and Vascular Endothelial Growth Factor-C (VEGF-C) which bind to and stimulate Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) but not Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3), and the use of the same in therapeutic applications in which the stimulation of angiogenesis and not lymphangiogenesis is desired.
Originalspråkengelska
Utgivningsår5 jul 2012
StatusPublicerad - 5 jul 2012
MoE-publikationstypH1 Beviljat patent

Citera det här

@misc{a0b91a6ff77546b0ad1c4f155f1cc073,
title = "VEGFR-2-specific forms of VEGF-D and VEGF-C and uses thereof",
abstract = "Amino-terminal truncated forms of Vascular Endothelial Growth Factor-D (VEGF-D) and Vascular Endothelial Growth Factor-C (VEGF-C) which bind to and stimulate Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) but not Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3), and the use of the same in therapeutic applications in which the stimulation of angiogenesis and not lymphangiogenesis is desired.",
author = "Alitalo, {Kari Kustaa} and Jeltsch, {Markku Michael} and Veli-Matti Lepp{\"a}nen and Aho, {Kukka Kanerva} and Andrey Anisimov and Denis Tvorogov",
year = "2012",
month = "7",
day = "5",
language = "English",
publisher = "WIPO",
address = "Switzerland",
type = "Patent",
note = "WO2012/088563",

}

VEGFR-2-specific forms of VEGF-D and VEGF-C and uses thereof. / Alitalo, Kari Kustaa; Jeltsch, Markku Michael; Leppänen, Veli-Matti; Aho, Kukka Kanerva; Anisimov, Andrey; Tvorogov, Denis.

WIPO. Patentnr.: WO2012/088563. jul 02, 2012.

Forskningsoutput: PatentVetenskaplig

TY - PAT

T1 - VEGFR-2-specific forms of VEGF-D and VEGF-C and uses thereof

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Markku Michael

AU - Leppänen, Veli-Matti

AU - Aho, Kukka Kanerva

AU - Anisimov, Andrey

AU - Tvorogov, Denis

PY - 2012/7/5

Y1 - 2012/7/5

N2 - Amino-terminal truncated forms of Vascular Endothelial Growth Factor-D (VEGF-D) and Vascular Endothelial Growth Factor-C (VEGF-C) which bind to and stimulate Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) but not Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3), and the use of the same in therapeutic applications in which the stimulation of angiogenesis and not lymphangiogenesis is desired.

AB - Amino-terminal truncated forms of Vascular Endothelial Growth Factor-D (VEGF-D) and Vascular Endothelial Growth Factor-C (VEGF-C) which bind to and stimulate Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) but not Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3), and the use of the same in therapeutic applications in which the stimulation of angiogenesis and not lymphangiogenesis is desired.

M3 - Patent

M1 - WO2012/088563

Y2 - 2012/07/02

PB - WIPO

ER -